Electrospinning technique has excellent advantages such as tunable functionality, thin fibers with large surface areas, ease of processing and good physical properties. Electrospinning provides wide usage area with these advantages in biomedical applications. Polylactic acid (PLA) is a biodegradable and biocompatible polymer, so it can be used in various biomedical applications. PLA can be easily electrospun from solution by using different kinds of conventional solvents. Electrospun PLA based nanofibers are used in many biomedical applications such as drug delivery, scaffold for tissue engineering, dressings for wound healing, dental applications etc. This review focuses on electrospun PLA based nanofibers used in biomedical applications in recent years. Future perspectives of electrospun PLA based fibers are also discussed in the last part.
Introduction
Polymeric nanofibers are a prime subclass of nanomaterials. The nanofibers have a diameter between 0.01 and 1 micrometer, in other words, they can range from micrometer to sub-micrometer levels.
1 They have excellent properties such as mimicable surface functionalities, good mechanical properties for example excellent stiffness and tensile strength and very high surface area to volume ratio. 2, 3 As shown in figure 1, there are several techniques to produce nanofibers. Techniques such as melt-spinning, 1,4 electrospinning, 1,2,5 phase separation, 1,6,7 template synthesis 1,8,9 and self-
Fig. 1: Techniques to produce nanofibers
assembly, 1,10 can be used to produce nanofibers. Among these methods, the most commonly used one is electrospinning method. This method is continuous, economical and easy. 1 Electrospinning process has four fundamental components (Fig. 2) . The first is a high voltage power supply ( Fig. 2A ) that gives power to get the charged polymer solution into a fiber form. The latter is a syringe pump (Fig. 2B ) to control the flow rate of the polymer solution. The third component is the needle to disperse charge on polymer jet (Fig. 2C) . The last one is the collector (Fig. 2D ) that picks up electrospun fibers by discharging them. 11, 12 Polymers used in nanofiber production are of importance due to mechanical, electrical and thermal properties. 13 Ideal polymers for biomedical applications should be both non-toxic, biodegradable, biocompatible and mechanically strong. Nanofibers can be manufactured from polymer/polymer blend melt or solution. Poly (lactic acid) (PLA), poly (vinyl alcohol) and polycaprolactone are examples of biocompatible polymers. Due to its biodegradability, biocompatibility and spinnability, PLA is a widely used polymer in electrospinning processes in versatile biomedical areas 14, 15 PLA can be easily dissolved in different kinds of conventional solvents such as acetone (AC), chloroform (CHL), dichloromethane (DCM), dimethylacetamide (DMAc), dimethylformamide (DMF), 1;4-dioxane (DX), tetrahydrofuran (THF). [16] [17] [18] [19] PLA can be produced by condensation polymerization and ring opening polymerization techniques. PLA obtained by condensation polymerization has low molecular weight and poor mechanical properties. Physical properties of PLA have shown excellent improvement with ring opening polymerization [20] . In this method, PLA is synthesized by using lactide monomer. Lactide is the cyclic dimer of lactic acid. As shown in figure 3, lactide can be found in different Poly-L-lactic acid (PLLA) occurs with polymerization of L-lactide. 21 Poly (lactide-co-glycolide) (PLGA) is one of the most commonly used copolymers of PLA in biomedical applications. PLGA occurs by copolymerization of PLA and polyglycolic acid (PGA). 22 Chemical structures of PLA, PLLA and PLGA are shown in the Figure 4 .
Nanofibers of PLA and PLA blends can be used in a wide variety of biomedical and biotechnological applications (Table 1) . Biomedical applications include drug release, scaffold for tissue engineering, dressings for wound healing and dental applications while biotechnological applications contain biosensors, molecular filtrations and preservations of biological agents.
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This review focuses on electrospun nanofibers of PLA and PLA blends used in biomedical applications in recent years. Advantages and limitations of electrospinning technique for biomedical applications are described in the review. In this study, biomedical applications are categorized as wound dressings, dental applications, controlled drug release and tissue engineering. Future perspectives related with electrospun PLA based nanofibers for biomedical applications were also discussed.
Biomedical Applications
The use of polymeric nanofibers for biomedical applications has some internal advantages such as deposition in fibrous forms or constructions and mimicking or replicating bio-systems. Wound dressings, dental applications, controlled drug release and tissue engineering are described in detail below within the context of biomedical applications.
Dressings for Wound Healing
There is an increasing demand for wound care products due to various types of wounds such as traumatic wounds, acute wounds and chronic wounds. With this demand, the development of dressing materials for wound healing is getting more importance.
1 An ideal dressing should provide an environment on the surface of the wound where the healing can occur at maximum rate consistent with wound healing and an acceptable cosmetic appearance.
1,37
The wound healing occurs in 4 fundamental phases (Fig. 5) . First phase is hemostasis phase (Fig. 5A) . The aim of this phase starting with the beginning of injury is to stop the bleeding. Second phase is called inflammatory phase (Fig.5B) . This phase destroys bacteria and prepares the wound bed for the growth of new tissue. Third phase is proliferation phase (Fig. 5C ). Filling the wound, contraction of Nguyen et al., has produced curcumin-loaded PLA nanofiber mats to develop a functional wound dressing. 23 PLA nanofibers had random fiber orientation and 971 ± 274 nm average diameter. The average diameter and distribution of the nanofiber diameters were decreased with increasing curcumin (Cur) amount. The tensile stress of PLA nanofibers was 2.5 MPa and it increased to level of 3.5 MPa with an increase in Cur levels from 0.125% to 1.25%. A further increase in Cur levels up to 6.25 wt% resulted in a decrease in tensile strength. Obtained mechanical properties were satisfactory for wound dressing materials. In vivo wound healing experiments were investigated using PLA and cur-loaded PLLA nanofiber treatments in a mouse model. In their study, PLA is preferred due to its biodegradability, biocompatibility and its ability to support the multiplication and binding of various cells. It was observed that tissue interaction with Cur increased because of the high porosity and large surface area.
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A sandwich-structured composite (SSC) was manufactured by Jinzhen Li et al. Layers were PVdF and enrofloxacin (Enro)/PLA while interface were Cur/PLA. Cur/PLA layer had diameters ranging from 2.29 to 4.62 µm and random fiber orientation. The tensile strength of SSC membranes was higher than 3.1 MPa. It was observed that SSC membranes showed both hydrophilic and hydrophobic surface character. The hydrophilic surface (Enro/PLA) was touched to the wound to release drugs for the wound healing. The hydrophobic surface (PVdF) was prevented penetration of moisture and also reduced the wound infection chance. Enro and Cur were distributed homogeneously in the SSC membrane matrix according to their results. These membranes had good biocompatibility, flexibility, mechanical strength and antibacterial effect against well-known bacterial cultures such as E. coli, S. pneumoniae, P. aeruginosa, S. aureus and C. albicans. 24 Ciprofloxacin (antibiotic)-loaded electrospun PLGA mats blended with sodium alginate were prepared by Liu et al., PLGA nanofibers had random fiber orientation and 777 ± 249 nm average diameter. The diameter of PLGA fibers were considerably decreased with the addition of sodium alginate. Addition of ciprofloxacin was not significantly affected the fiber diameters in comparison with diameters of PLGA/sodium alginate fibers. Wetting capability of sodium alginate was increased capacity of water absorption according to their results. Water uptake was increased with addition of sodium alginate. The stiffness of PLGA mat was decreased with adding sodium alginate, so the injured area was protected much better. The tensile strengths of produced mats were higher than 3 MPa. The burst release of ciprofloxacin was supplied advanced antibacterial effect to the PLGA mats with adding sodium alginate. 25 Low formation of blood vessels (angiogenesis) and late wound closure are seen in diabetic patients. PLLA electrospun membranes including dimethyloxalylglycine (DMOG)-loaded mesoporous silica nanoparticles (DS) was fabricated for diabetic wound healing by Ren et al., PLLA electrospun mats had aligned fibers with around 3000 -5000 nm diameter and elliptic-shaped pores on the surface of fibers. Also, the diabetic mice were used for analysis of wound healing efficiency in their study. Produced nanofibers were placed in the dorsal area of mice. The wound area was decreased with time. In the end of 15 days, around 94% healing ratios had been seen. 26 
Nanofibrous Scaffolds for Tissue Engineering
Biodegradable scaffolds can be seen as an important class for tissue engineering. They are utilized as temporary templates prior to renewing of natural extracellular matrix or biologically functional tissue. The similarity of the fibrous scaffold with native tissue is significant which allows the growth of the artificial texture. The fibrous scaffolds should allow copying the physical structure of the natural extracellular matrix for regeneration of tissue.
1, 39, 40 The usage areas of nanofibers are determined according to their physical and chemical properties such as porosity, biodegradability and mechanical properties. Nanofibers can be used in many tissue engineering applications such as cardiac, [41] [42] [43] [44] nerve, [45] [46] [47] [48] [49] bone [50] [51] [52] [53] [54] and skin. [55] [56] [57] [58] [59] These areas are described in detail within the following sections.
Nanofibers for Cardiac Tissue Engineering
Heart diseases are one of the main causes of death. 366,800 people are died a year due to coronary heart disease according to American Heart Association statistics in 2018. It means that 1 in 7 deaths in the US are because of coronary heart disease. According to World Health Organization statistics, ischemic heart disease remains the first cause of death in the world. 60, 61 Cardiac tissue engineering presents new solutions for patients with heart failure.
12, [62] [63] [64] As shown in figure 6, firstly scaffold for cardiac tissue should be prepared. Then, seeding of repairing cells into scaffold should be carried out in order to generate cardiac grafts. In the final step, cardiac tissue construct should be transplanted onto heart for heart regeneration.
Zong et al., worked with electrospun PLGA-based scaffolds to produce of cardiac tissue constructs. Average diameter of fibers was 1 µm. After fibers were produced as random, they were uniaxially stretched. Scaffolds were investigated for the attachment and growth of the cardiac myocytes (CMs). Hydrophobic surfaces were comparatively preferred by CMs. When the amount of GA in PLGA was increased, degradation rate was increased and pH was decreased. CMs were badly affected because of faster degradation rate. Optical mapping of electrical activity was prepared in cultured CMs. Shorter action potential durations and external pacing rates up to 6 Hz were exhibited by cultured CMs on PLLA membranes., according to their results, electrospun PLGA scaffolds were ensured guidance and flexibility to grow CMs. PLGA scaffolds were used favorably to get cardiac tissue. 27 In another study, vascular scaffolds were fabricated as a native vessel by Stitzel et al. Elastin, collagen and PLGA were used with different ratios for this study. Produced scaffolds were designed to be 1 mm thick and 12 cm long. In their study, fibers had diameters of 0.72 ± 0.35 µm and a random orientation. Mechanical properties of vascular scaffolds were improved by adding PLGA. While the diameter change of the natural vessel was 9%, the diameter change of the electrospun scaffolds was 12-14%. This was the evidence of similar behavior between the natural vessels and the electrospun scaffolds. According to their results, produced scaffolds were resisted at nearly 12 times higher pressure than systolic pressure -taken during each beat of the heart. Endothelial and smooth muscle cells were used for biocompatibility test. An average of 82% of smooth muscle cells and 72% of endothelial cells were stayed alive on the scaffold according to mitochondrial metabolic activity assay. An average of 80% of smooth muscle cells and the endothelial cells were stayed alive on the scaffold according to neutral red assay. The biocompatibility of the produced scaffolds were demonstrated using in vivo mice models. This study was showed the promise of a functional vascular graft in clinical applications. 28 Drug-eluting cardiovascular stents have been developed to avoid blood clot in recent years. Dipyridamole is a well-known medication and inhibits blood clot formation. Drug-eluting cardiovascular stents were fabricated by Bakola et al. In their study, dipyridamole loaded PLA nanofibers were prepared. Produced PLA fibers had 522 nm average fiber diameter and a random orientation. Hydrophobic behavior was exhibited by PLA and dipyridamole loaded PLA scaffold according to contact angle measurements. Contact angle of PLA and dipyridamole loaded PLA scaffolds were observed at 124.9° ± 0.4 and 129.3° ± 1.7, respectively. While roughness and surface wetting properties of scaffold were decreased with the addition of the drug, contact angle values and scaffold's hydrophobicity were increased. Dipyridamole loaded PLA scaffold was placed upon cardiovascular Co/Ni stent. Well scaffold morphology and enough adhesion upon the stent was observed.
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Nanofibers for Nerve Tissue Engineering
Regeneration within a hollow nerve guidance conduit (NGC) is observed to understand nerve regeneration. As shown in figure 7, regeneration process is comprised of 5 main phases. These phases are the fluid phase, the matrix phase, the cellular migration phase, the axonal phase and the myelination phase. 65, 66 First phase is nerve conduit repair. An influx of plasma exudate is released from both the proximal and distal nerve stumps in the initial fluid phase (Fig. 7A) . [65] [66] [67] [68] Second phase is formation of fibrin cable between the proximal and distal stumps (Fig. 7B) . Cell migration, proliferation and alignment and tissue cable formation is occurred in the third phase (Fig. 7C) . [65] [66] [67] Growth of axons should be seen in the fourth phase (Fig. 7D) . Axonal fibers are used as guidance in the myelination phase (Fig. 7E) . 66 Developing neural guidance conduits and directing the extension of nerve cells are the main objectives of nerve tissue engineering. One of the important factors of tissue engineering is bioactive molecules. Especially in nerve tissues, neurogenesis is increased by bioactive molecules. These molecules are expensive, unstable and also have also side effects, generally. 69 According to literature, electrospun nanofibers with different morphologies and structures (oriented, hollow, core-sheath, sponge-like threads etc.) are suitable for nerve regeneration.
12, 70 Electrospun nanofibers loaded with active molecules such as laminin 30 , melanin, 71 gelatin, 45 fibrinogen from bovine plasma 72 and lycium barbarum polysaccharide 69 are good candidates to fulfill scaffold requirements for nerve regeneration.
Koh et al., studied the laminin loaded PLLA nanofibers for nerve regeneration applications. Three different methods were used in their study. After PLLA nanofibers were produced by electrospinning, plasma-treatment and chemical bonding of laminin onto PLLA nanofibers was used in the first method. In the second method, after electrospinning PLLA nanofibers, plasma-treatment and physical adsorption of laminin onto PLLA nanofibers was made. In the last method, only electrospinning method was performed with blended laminin-polymer solution to obtain laminin loaded PLLA nanofibers.
Fig. 7: Schematic representation of nerve regeneration
PLLA and functionalized laminin-PLLA random nanofibers were consisted of nanofibers in the diameter range of 100-500 nm. Uniform distribution of laminin was observed on the nanofibers according to morphological characterization. According to their results, blended laminin-PLLA nanofibers had more laminin comparing to others and also showed better neurite growth rate compared with other chemical and physical bonding routes.
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Nanofibers for Bone Tissue Engineering
Bone is a strong, rigid and hard binding tissue by contrast with soft tissue. Natural bone is an organicinorganic biocomposite. It consists of 30% of organic matrix and 70% inorganic crystals by weight. Bone grafts are good choices after bone fracture, loss and infection. They must ensure suitable environment for osteogenesis.
12, 55 Bone formation can occur in two ways: intramembranous and endochondral bone formation. Intramembranous bone formation includes bone tissue formation from embryonic connective tissue. In endochondral bone formation, hyaline cartilage occurs as outline of the future bone. Cartilage tissue is damaged in this formation and formed the basis for bone tissue. 73 Bone reparation contains repeated bone formations, so there should be no scar on bone at the end of healing period. Intramembranous bone formation starts at cortex and periosteum. The fracture is stabilized by external soft tissues, and then cartilage occurs. While tissues grow mature and the matrix calcifies, formation of cartilage decreases. Chondroclasts are carried by growing blood vessels, then new bone formation start. While new bone reshape, mechanical continuity is provided. 74 As shown in figure 8, bone healing mechanism occurs in 3 steps. Each step is related with the mechanical aspects. First step involves the bone mechanical properties and loading conditions. Scaffold should not contain a stress-shielding effect at this step. So, the scaffold's elastic modulus should not be higher than that of the main bone. Interface biomechanics is the second step. The scaffold mechanical properties adjust to manufacture scaffold-bone mechanotransduction at the second step. This mechanotransduction affects the differentiation of tissue. 75 Third step known as final fixation includes degradation of scaffold. When scaffold degrades, the mechanical load is supported by ingrown bone. 76 Electrospun nanofibers loaded with active bone healers such as hydroxyapatite (HA), 31, [77] [78] [79] [80] β-tricalcium phosphate (β-TCP), 81 collagen (coll), 51, 82 siloxane 83 and zinc-cur 84 are good candidates to fulfill scaffold requirements for aforementioned bone healing mechanism.
PLLA, PLLA/hydroxyapatite(HA) and PLLA/coll/ HA scaffolds were fabricated by Prabhakaran et al. Fiber diameters of the electrospun PLLA, PLLA/ HA and PLLA/coll/HA nanofibers were 860 ± 110, 845 ± 140, 310 ± 125 nm, respectively. Produced nanofibers had a random orientation and bead free. While average fiber diameters of PLLA and PLLA/ HA were similar, fiber diameters were decreased considerably with collagen addition. The average tensile strength of PLLA, PLLA/HA and PLLA/coll/ HA scaffolds were 4.69 ± 0.19, 3.10 ± 0.15, 2.05 ± 0.10 MPa, respectively. Elongation at break was also similar for PLLA (25%) and PLLA/coll/HA (28.95%) scaffolds. In their study, proliferation of human fetal osteoblasts (hFob) and mineralization process were investigated. Proliferation on PLLA/ HA scaffold was better than proliferation on PLLA scaffold. Among their samples, the best proliferation was seen in PLLA/coll/HA scaffolds. According to their morphological results, the best mineralization was also seen in PLLA/coll/HA scaffolds.
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Nanofibers for Skin Tissue Engineering
Nanofiber scaffolds preserve the wound field from decrement of fluid and proteins and bring better appearance. Fibers support cell adhesion and proliferation. Therefore, nanofiber scaffolds show promise for skin tissue engineering. 55, 57 Electrospun nanofibers loaded with active materials such as silk fibroin 85 , bioactive glass 86 , gelatin 87, 88 and poloxamer 58 are good candidates to fulfill scaffold requirements.
Poly(p-dioxanoneco-L-lactide) block-poly(ethylene glycol) scaffolds were produced by Bhattarai et al., Copolymer were consisted of random nanofibers in the diameter of 1.4 µm. This product had >80% porosity and 1.4 MPa tensile strength. Proliferation, fibroblast adhesion and cell growth along the fiber were promoted by the scaffolds.
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Drug Release
Release of drugs or pharmaceutical agents in desired ratio is very important for patients.
1 A drug release system is designed to check drug delivery in desired ratio and time.
12,89 Drug release with polymer nanofibers, one of the new technologies, has some advantages due to their high aspect ratio. The rate of drug release can be determined by nanofiber characteristics such as fiber diameter, porosity and fiber/drug binding properties.
12, 90 The structure of the polymer and the state of the drug are very important at the nanofiber-based drug delivery systems. A fast burst release and then a slower sustained release are occurred at the drug release from semi-crystalline polymer nanofibers 33 The interaction between drug and the polymer also affects nanofiber-based drug delivery system. [91] [92] [93] There are three main mechanisms for a controlled drug delivery system. These are diffusion, chemical reaction and solvent activation. Diffusion-controlled system is the most common drug delivery system. 93, 94 The rate of drug diffusion is affected by different factors such as molecular geometry, drug-matrix interactions, etc. Encapsulated drug is a large hydrophilic molecule, so it cannot diffuse through the polymer. Thus, polymer swells with osmotic pressure. It is called true release mechanism. If the release mechanism is described as the drug release way, a 4-step release process occurs in that system. As shown in figure 9, these are diffusion through waterfilled pores (Fig.9A) , diffusion through the polymer (Fig.9B), osmotic pumping (Fig.9C) and erosion (Fig.9D) . 95 Various drugs such as tetracycline 33, cyclosporine A (CsA), 34 rhodamine B (RhB), 35 dipyridamole, 29 ketoprofen (KET) 96-98 are used in drug release.
The study of Kenawy et al., is the first report for drug release from electrospun polymers. Electrospun mats of PLA, poly (ethylene-co-vinylacetate) (PEVA) and PLA/PEVA blend were produced in their study. PLA/PEVA nanofibers were consisted of random nanofibers in the diameter range of 1-3 µm. Tetracycline release of mats was observed in their study. The drug release was relatively smooth during 5 days according to their results. This work demonstrates that electrospun polymer matrixes can be used in controlled release technology. . The pharmacological activity of CsA was not changed during the process. The CsA in culture environment was released during at least 96 hours. At the same time, 35 percent of the drug was still conserved inside the nanofibers on day 8. CsAloaded nanofibers were added inside mouse spleen cells. According to their results, PLLA nanofibers can be used as drug carriers and scaffolds. 34 In another study, electrospun PLA/graphene oxide (GO) nanofiber membranes for drug release were produced by Mao et al. Produced nanofibers as co-axial structure were consisted of random nanofibers in the diameter range 549.7 ± 153.1 nm for co-axial structure with 25 mg mL -1 of GO. Rhodamine B (RhB) was used as a drug model. The release of RhB from the nanofibers was increased with addition of GO. According to the results, PLA/ GO nanofiber membranes were good option for drug release systems. 35 Drug-eluting cardiovascular stents were fabricated by Bakola et al., as described in the cardiac tissue engineering section, previously. Drug-release of the dipyridamole loaded PLA scaffold was discussed within this section. The pharmacokinetics of dipyridamole loaded PLA scaffolds was observed for nearly 7 months. 13% dipyridamole was released at first burst after the first 24 hours. Slow and controlled release was observed subsequently. 82% dipyridamole was released in 182 days. 100% of the drug was released in 218 days at last. According to their results, extreme drug release was observed in the first 24 hours. While the polymeric matrix disintegrated, constant and controlled drug release was observed. Lastly, drug release was slow and low. 29 
Dental Applications
Periodontal diseases are the common cause of tooth loss. Connective tissue weakens and bone support is lost with this disease. 36, 99 There are some traditional treatment methods like stem cell therapy, 100 guided tissue regeneration (GTR) 36 and bone graft 101 for periodontal diseases. GTR is the most promising traditional treatment methods 36, [102] [103] [104] [105] [106] GTR treatment (Fig. 10) involves implanting a regeneration membrane to restore the tissue. 36, 102 Regeneration membrane must be biocompatible to complete tissue regeneration. 36 Nonresorbable materials such as expanded polytetrafluoroethylene (e-PTFE) were used in the first GTR treatments. 36, 105 However, these materials make it difficult to make the necessary stitches and require a second surgical procedure to remove these materials. 36, 107 Before regeneration of tissues and bone defects, a regeneration membrane should be degraded quickly. For this reason, naturederived materials, i.e. PLA, are good candidates due to their controllable degradation time and biocompatibility. 36, 108 PLLA has been used in dental surgery due to its easy processability and biodegradability. 36, 109 Trejo et al. implanted PLLA barriers of 30 patients for intrabony defects. The cure was showed result well, Chen et al., fabricated successfully PLLA/chitosan membrane for the regeneration of periodontal guided tissues. After PLLA was produced with electrospinning method, chitosan was grafted on PLLA fibers. PLLA-CS nanofibers were consisted of random nanofibers in the diameter range of 2.76 ± 0.72 µm. Hydrophilicity, degradation and the biocompatibility was increased with chitosan according to their results.
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Conclusion
Electrospun PLA-based nanofibers show great potential in biomedical applications (drug release, scaffolds for tissue engineering including nerve, bone, skin, cardiac tissues, dental and wound healing applications) due to their unique advantages such as high porosity, high surface area to volume ratio, sustainability, biocompatibility and biodegradability. Moreover some physical properties of nanofibers, such as surface morphology, fiber diameter, porosity etc., can be controlled, changed or mimicked easily by controlling electrospinning process parameters. In spite of these advantages, electrospinning process has some difficulties for biomedical applications. Difficulties in the production of 3D scaffolds with macro pores and scaling up into industrial scale are the major problems. In order to overcome these problems, new electrospinning-based techniques such as edge spinning, needleless electrospinning, near-field electrospinning etc., can be used for biomedical applications.
Lastly, most of the academic research related with PLA-based nanofibers has been made as in vitro and in vivo studies, and it's very limited. Limited clinical applications is one of the obstacles to the commercialization of PLA-based medical devices, therefore more research is required on the clinical applications of PLA based fibers. 
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